» Articles » PMID: 37572666

Obesity-associated Microglial Inflammatory Activation Paradoxically Improves Glucose Tolerance

Abstract

Hypothalamic gliosis associated with high-fat diet (HFD) feeding increases susceptibility to hyperphagia and weight gain. However, the body-weight-independent contribution of microglia to glucose regulation has not been determined. Here, we show that reducing microglial nuclear factor κB (NF-κB) signaling via cell-specific IKKβ deletion exacerbates HFD-induced glucose intolerance despite reducing body weight and adiposity. Conversely, two genetic approaches to increase microglial pro-inflammatory signaling (deletion of an NF-κB pathway inhibitor and chemogenetic activation through a modified Gq-coupled muscarinic receptor) improved glucose tolerance independently of diet in both lean and obese rodents. Microglial regulation of glucose homeostasis involves a tumor necrosis factor alpha (TNF-α)-dependent mechanism that increases activation of pro-opiomelanocortin (POMC) and other hypothalamic glucose-sensing neurons, ultimately leading to a marked amplification of first-phase insulin secretion via a parasympathetic pathway. Overall, these data indicate that microglia regulate glucose homeostasis in a body-weight-independent manner, an unexpected mechanism that limits the deterioration of glucose tolerance associated with obesity.

Citing Articles

Interleukin-2 improves insulin sensitivity through hypothalamic sympathetic activation in obese mice.

Moon S, Park Y, Jang S, Kim S, Song D, Shin D J Neuroinflammation. 2024; 21(1):250.

PMID: 39367382 PMC: 11453069. DOI: 10.1186/s12974-024-03244-y.


Microglia Mediate Metabolic Dysfunction From Common Air Pollutants Through NF-κB Signaling.

Debarba L, Jayarathne H, Stilgenbauer L, Dos Santos A, Koshko L, Scofield S Diabetes. 2024; 73(12):2065-2077.

PMID: 39320947 PMC: 11579412. DOI: 10.2337/db24-0110.


Microglia in physiological conditions and the importance of understanding their homeostatic functions in the arcuate nucleus.

Guzman-Ruiz M, Guerrero Vargas N, Ramirez-Carreto R, Gonzalez-Orozco J, Torres-Hernandez B, Valle-Rodriguez M Front Immunol. 2024; 15:1392077.

PMID: 39295865 PMC: 11408222. DOI: 10.3389/fimmu.2024.1392077.


Microglia mediate the early-life programming of adult glucose control.

Valdearcos M, McGrath E, Brown Mayfield S, Folick A, Cheang R, Li L bioRxiv. 2024; .

PMID: 39005380 PMC: 11244970. DOI: 10.1101/2024.07.02.601752.


Obesity-induced inflammation: connecting the periphery to the brain.

Le Thuc O, Garcia-Caceres C Nat Metab. 2024; 6(7):1237-1252.

PMID: 38997442 DOI: 10.1038/s42255-024-01079-8.

References
1.
Jais A, Bruning J . Arcuate Nucleus-Dependent Regulation of Metabolism-Pathways to Obesity and Diabetes Mellitus. Endocr Rev. 2021; 43(2):314-328. PMC: 8905335. DOI: 10.1210/endrev/bnab025. View

2.
Uner A, Kecik O, Quaresma P, De Araujo T, Lee H, Li W . Role of POMC and AgRP neuronal activities on glycaemia in mice. Sci Rep. 2019; 9(1):13068. PMC: 6736943. DOI: 10.1038/s41598-019-49295-7. View

3.
Morton G, Matsen M, Bracy D, Meek T, Nguyen H, Stefanovski D . FGF19 action in the brain induces insulin-independent glucose lowering. J Clin Invest. 2013; 123(11):4799-808. PMC: 3809800. DOI: 10.1172/JCI70710. View

4.
Gao Y, Vidal-Itriago A, Kalsbeek M, Layritz C, Garcia-Caceres C, Tom R . Lipoprotein Lipase Maintains Microglial Innate Immunity in Obesity. Cell Rep. 2017; 20(13):3034-3042. DOI: 10.1016/j.celrep.2017.09.008. View

5.
McKinsey G, Lizama C, Keown-Lang A, Niu A, Santander N, Larpthaveesarp A . A new genetic strategy for targeting microglia in development and disease. Elife. 2020; 9. PMC: 7375817. DOI: 10.7554/eLife.54590. View